207 related articles for article (PubMed ID: 16233931)
1. Serum cholinesterase activity in diabetes and associated pathologies.
Inácio Lunkes G; Stefanello F; Sausen Lunkes D; Maria Morsch V; Schetinger MR; Gonçalves JF
Diabetes Res Clin Pract; 2006 Apr; 72(1):28-32. PubMed ID: 16233931
[TBL] [Abstract][Full Text] [Related]
2. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
3. Effect of high glucose levels in human platelet NTPDase and 5'-nucleotidase activities.
Lunkes GI; Lunkes DS; Leal D; Araújo Mdo C; Corrêa M; Becker L; Rosa CS; Morsch VM; Schetinger MR
Diabetes Res Clin Pract; 2008 Sep; 81(3):351-7. PubMed ID: 18644642
[TBL] [Abstract][Full Text] [Related]
4. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F
Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of elderly diabetics with or without hypertension and hyperlipidemia.
Goriya Y; Suzuki T; Takizawa S; Natto M
J Environ Pathol Toxicol Oncol; 2000; 19(1-2):159-65. PubMed ID: 10905522
[TBL] [Abstract][Full Text] [Related]
6. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
Alghasham AA; Barakat YA
Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of insulin sensitizers in diabetes.
Jawa A; Fonseca V
Curr Opin Investig Drugs; 2006 Sep; 7(9):806-14. PubMed ID: 17002258
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term glycaemic control and the state of the renin system in type 1 diabetes mellitus.
Stevanovic RD; Fisher ND; Lansang CM; Freeman KD; Hollenberg NK
J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):85-92. PubMed ID: 17703435
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
[TBL] [Abstract][Full Text] [Related]
12. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
[TBL] [Abstract][Full Text] [Related]
13. Serum beta-glucuronidase activity in diabetic patients as related to vascular complications and degree of glucose metabolic disorder.
Belfiore F; Lo Vecchio L; Napoli E
Am J Med Sci; 1972 Dec; 264(6):457-66. PubMed ID: 4631176
[No Abstract] [Full Text] [Related]
14. [Levels of soluble adhesion molecules among normal and hypertensive type 2 diabetic patients].
Rubio-Guerra AF; Vargas-Robles H; Medina-Santillán R; Escalante-Acosta BA
Gac Med Mex; 2008; 144(1):11-4. PubMed ID: 18619052
[TBL] [Abstract][Full Text] [Related]
15. [Protective effects of Huanglian Jiedu decoction on vascular endothelial function in type 2 diabetic rats].
Xiao YL; Lu FE; Xu LJ; Leng SH; Wang KF
Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(22):1767-70. PubMed ID: 16468376
[TBL] [Abstract][Full Text] [Related]
16. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
[TBL] [Abstract][Full Text] [Related]
17. Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes.
Martina V; Masha A; Gigliardi VR; Brocato L; Manzato E; Berchio A; Massarenti P; Settanni F; Della Casa L; Bergamini S; Iannone A
Diabetes Care; 2008 May; 31(5):940-4. PubMed ID: 18268065
[TBL] [Abstract][Full Text] [Related]
18. Possible antidiabetic and antihyperlipidaemic effect of fermented Parkia biglobosa (JACQ) extract in alloxan-induced diabetic rats.
Odetola AA; Akinloye O; Egunjobi C; Adekunle WA; Ayoola AO
Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):808-12. PubMed ID: 16922811
[TBL] [Abstract][Full Text] [Related]
19. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
20. Breast arterial calcifications associated with diabetes and hypertension.
Cetin M; Cetin R; Tamer N; Kelekçi S
J Diabetes Complications; 2004; 18(6):363-6. PubMed ID: 15531187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
